---
schema_version: "secwatch.filing_event.v1"
accession: "0000785161-23-000058"
form_type: "8-K"
ticker: "EHC"
cik: "0000785161"
company_name: "Encompass Health Corp"
filed_at: "2023-09-27T23:59:59+00:00"
generated_at: "2026-06-10T08:25:57.819470+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Encompass Health reaffirms 5-year growth targets; RCD affirmation >95% in Alabama

## Summary
- Five-year targets (2023-27): 6-10 de novos/year, 80-120 bed additions/year, 6-8% discharge CAGR.
- Q3 volume trends positive; RCD in Alabama: ~440 records submitted, >95% affirmation rate vs 80% target.
- H1 2023 adjusted EBITDA $478.6M; adjusted EPS from continuing ops $1.83 (diluted).
- 2023 interest expense estimate $145-155M; amortization approx $10M.
- Non-GAAP measures reconciled; company reiterates focus on organic growth and regulatory initiatives.

## SEC filing metadata
- accession: 0000785161-23-000058
- form_type: 8-K
- ticker: EHC
- cik: 0000785161
- company_name: Encompass Health Corp
- filed_at: 2023-09-27T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/785161/000078516123000058/0000785161-23-000058-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/785161/000078516123000058/ehc-20230927.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000785161-23-000058
- JSON: https://secwatch.observer/filing/0000785161-23-000058.json
- Plain text: https://secwatch.observer/filing/0000785161-23-000058.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.